Detalhe da pesquisa
1.
CRISPR/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells.
Proc Natl Acad Sci U S A
; 116(52): 26846-26852, 2019 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31818947
2.
A scalable, GMP-compatible, autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa.
bioRxiv
; 2023 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36909618
3.
Engineering human skin model innervated with itch sensory neuron-like cells differentiated from induced pluripotent stem cells.
Bioeng Transl Med
; 7(1): e10247, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35111948
4.
Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression.
Nat Cancer
; 2(8): 803-818, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35122025
5.
Engineering tissue-specific blood vessels.
Bioeng Transl Med
; 4(3): e10139, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31572797
6.
Brief report: embryonic growth and hatching implications of developmental 670-nm phototherapy and dioxin co-exposure.
Photomed Laser Surg
; 24(3): 410-3, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16875452
7.
Targeting the Jak/Signal Transducer and Activator of Transcription 3 Pathway with Ruxolitinib in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa-Squamous Cell Carcinoma.
J Invest Dermatol
; 141(4): 942-946, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33069729
8.
How well can an idiotope peptide mimic replace its parent idiotype in a synthetic peptide vaccine?
Pharm Res
; 21(8): 1480-8, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15359585